StockWatch
·
FILATEX INDIA LTD.-$ · Q2 FY-2027 · PREVIEW

Tracking FY27 Revenue Scale-Up and FTA-Led Margin Lift

FILATEX heads into Q2 with Q1 momentum intact—16% sequential growth in revenue and 22% profit jump. The Street watches whether the company sustains this trajectory toward its full-year target of ₹4,600–4,700 Cr and the 30% profit uplift from new capacity and trade tailwinds.

Q2 FY27 resultsFILATEXFILATEX INDIA LTD.-$11 Nov 2026 · 3 min read

The Setup: Momentum in Motion

FILATEX opened FY27 with force. Q1 saw revenue climb 16% sequentially (to ~₹1,050 Cr standalone) and net profit surge 22% QoQ to ₹49.1 Cr. This wasn't a one-off bounce—the company is executing on its full-year playbook: new manufacturing capacity ramping, Free Trade Agreement tailwinds improving margins, and subsidiary strategy (Ecosis) positioning for export revenue. For Q2, the bar is clear: sustain that revenue momentum and hold margin steady as mix normalizes post-summer.

Q2 Revenue Expectation

~₹1,120 Cr

16% sequential growth from Q1 run-rate; consistent with H1 pacing toward FY27 target of ₹4,600–4,700 Cr

Net Profit Range

~₹50–54 Cr

If growth trajectory holds from Q1's 22% QoQ surge and 30% YoY profit target materializes

EBITDA Margin Watch

~7.5–8.2%

Q1 FY27 trajectory; FTA benefits to lift across H2 as new capacity utilization improves

What a strong Q2 looks like: Revenue crosses ₹1,150 Cr (accelerating run-rate toward midpoint of full-year guide) with EBITDA margin holding or expanding to 8.0%+. Profit above ₹52 Cr on stable tax rate. What a weak Q2 looks like: Revenue stalls below ₹1,080 Cr (momentum loss), margin compresses below 7.3%, or profit falls to ₹48 Cr or lower (suggesting capacity ramp delays or input cost headwinds).

On Track?

Yes, broadly. The FY27 revenue target of ₹4,600–4,700 Cr implies ~₹1,150–1,175 Cr per quarter on a normalized basis; Q1 at ~₹1,050 Cr + growth suggests H2 upside as capacity ramps. The 30% profit growth target (from FY26's base) also appears intact if Q1's 22% QoQ bounce sustains. However, the real test is whether the Dahej fire disruption (Oct 3—now resolved) had any lingering effect on October utilization, and whether FTA margins stick as promised.

Since Last Quarter: Strategic Capex, Operational Grit

Key Filings & Events Since Q1 FY27 (Jul 30 – Nov 10, 2026)

Sep 24, 2026

Event

₹20 Cr investment in Ecosis subsidiary (2 Cr shares @ ₹10 each)

Flag

Strategic capex; export/Spain foray

Sep 22, 2026

Event

36th AGM held; ₹0.30 dividend declared & approved

Flag

Routine; healthy capital return

Sep 04, 2026

Event

Yaduraj Bhageria (promoter) acquires 1.5L shares @ market

Flag

Promoter confidence signal

Aug 31, 2026

Event

FY26 Annual Report & BRSR filed; record date Sep 15 for ₹0.30 dividend

Flag

Routine governance

Aug 28, 2026

Event

Anurag Choudhary & PAC sell 2.12% stake (~94 Lakh shares @ ₹84–85)

Flag

Insider selling; pace-of-growth uncertainty flagged

Oct 03, 2026

Event

Minor fire at Dahej plant central store; controlled within 2 hrs, no injuries, zero production loss

Flag

Operational resilience; no material impact

Nov 07, 2026

Event

Additional ₹1.3 Cr investment in Ecosis (1.3 Cr shares @ ₹10 each)

Flag

Continued subsidiary build-out

Strategic reading: The ₹20+ Cr Ecosis capex signals a serious push into export/international revenue (Spain subsidiary established). This supports the margin and scale thesis for FY27. The Dahej fire was well-handled operationally—no downtime, a reassuring signal. Promoter buying by Yaduraj Bhageria suggests conviction at ₹84–85 levels. The 2.12% Anurag Choudhary/PAC exit in late August is worth noting but not a dealbreaker; exits often reflect portfolio rebalancing rather than thesis abandonment. Dividend at ₹0.30 per share (vs ₹0 last year) shows capital confidence.

On Result Day (Nov 13): 3 Numbers That Matter
  • 1 · Revenue Hold Above ₹1,100 Cr

    Confirms sequential growth momentum from Q1's ₹1,050 Cr baseline. Below ₹1,080 Cr would signal either capacity constraint or demand softness—red flag for full-year guidance.

  • 2 · EBITDA Margin ≥ 7.5% (Standalone)

    The swing metric. If margins compress below 7.3%, the 30% profit growth thesis weakens. If they hold or expand to 8%+, FTA benefits are real and H2 looks strong.

  • 3 · Segment Flavor: Export vs Domestic Revenue Mix

    Monitor Ecosis/export contribution. If it's ramping (even if modest in Q2), it's proof of concept for the international pivot and margin accretion. If flat/negligible, capex is still early stage.

FILATEX enters Q2 with Q1 energy. Revenue climbing steadily (~16% QoQ), profit rebounding sharply (22% QoQ), and the full-year script intact: ₹4,600–4,700 Cr revenue, 30% profit growth, margin lift from FTAs and capacity. The stock is down 18% from its ATH (₹114.25 → ₹93.94 now), making sentiment cautious, but the operational trajectory is sound. Key risk: if Q2 revenue stalls below ₹1,100 Cr or margin cracks, full-year targets become questionable. Key upside: if both metrics hold and Ecosis exports begin visible contribution, FY27 becomes a re-rate story on improved visibility. Watch revenue, margin, export ramp, and any commentary on H2 capacity utilization on the call.

Informational and educational content only. Not investment advice.